These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38124908)

  • 1. Retracted: Effect of Dapagliflozin on Clinical Outcome after Drug-Eluting Stent Implantation in Elderly T2DM Patients: A Real-World Study.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9837890. PubMed ID: 38124908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Dapagliflozin on Clinical Outcome after Drug-Eluting Stent Implantation in Elderly T2DM Patients: A Real-World Study.
    Lin Y; Zhou F; Wang X; Guo Y; Chen W
    Comput Math Methods Med; 2023; 2023():8441396. PubMed ID: 37455683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9830309. PubMed ID: 37387820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.
    Iakovou I; Schmidt T; Bonizzoni E; Ge L; Sangiorgi GM; Stankovic G; Airoldi F; Chieffo A; Montorfano M; Carlino M; Michev I; Corvaja N; Briguori C; Gerckens U; Grube E; Colombo A
    JAMA; 2005 May; 293(17):2126-30. PubMed ID: 15870416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease.
    Lee SP; Suh JW; Park KW; Lee HY; Kang HJ; Koo BK; Chae IH; Choi DJ; Rha SW; Bae JW; Cho MC; Kwon TG; Bae JH; Kim HS;
    Trials; 2010 Aug; 11():87. PubMed ID: 20735821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9824960. PubMed ID: 38124921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Real DAPSI: A Real-World Retrospective Study on Assessing the Efficacy and Safety of a Fixed-Dose Combination of Dapagliflozin and Sitagliptin in the Indian Population.
    Bhattacharjee R; Rai M; Joshi P; Prasad A; Birla A
    Cureus; 2023 Oct; 15(10):e46767. PubMed ID: 37954782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 7-Year, Real-World Clinical Outcomes between Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Drug-Eluting Stent In-Stent Restenosis.
    Kim M; Jang AY; Lee J; Seo J; Shin YH; Oh PC; Suh SY; Lee K; Kang WC; Han SH
    J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal duration of dual antiplatelet therapy following treatment with the endeavor zotarolimus-eluting stent in real-world Japanese patients with coronary artery disease (OPERA): study design and rationale.
    Nakamura M; Nanto S; Hirayama A; Takayama T; Nishikawa M; Kimura K; Morita S; Aizawa T; Asano R; Matsumaru Y; Hamada C; Isshiki T;
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):368-74. PubMed ID: 24382824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes following coronary drug-eluting- and bare-metal-stent implantation.
    Auer J; Leitner A; Berent R; Lamm G; Lassnig E; Krennmair G
    Atherosclerosis; 2010 Jun; 210(2):503-9. PubMed ID: 20060973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.
    Burzotta F; Brancati MF; Trani C; Porto I; Tommasino A; De Maria G; Niccoli G; Leone AM; Coluccia V; Schiavoni G; Crea F
    Trials; 2012 May; 13():55. PubMed ID: 22559260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: The Predictive Effect of Negative Psychological Emotions of Anxiety and Depression on the Poor Prognosis of CHD Patients with Stent Implantation and the Improvement of Clinical Intervention Measures.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9828721. PubMed ID: 38094363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical results and predictors of adverse outcomes after drug-eluting stent implantation for bifurcation lesions in a real-world practice: the COBIS (Coronary Bifurcation Stenting) registry.
    Gwon HC; Choi SH; Song YB; Hahn JY; Jeong MH; Seong IW; Kim HS; Rha SW; Yang JY; Yoon JH; Tahk SJ; Seung KB; Jang Y; Park SJ
    Circ J; 2010 Nov; 74(11):2322-8. PubMed ID: 20890049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study.
    Thim T; Johansen MB; Chisholm GE; Schmidt M; Kaltoft A; Sørensen HT; Thuesen L; Kristensen SD; Bøtker HE; Krusell LR; Lassen JF; Thayssen P; Jensen LO; Tilsted HH; Maeng M
    BMC Cardiovasc Disord; 2014 Aug; 14():100. PubMed ID: 25125079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended Dual Antiplatelet for Diabetic Elderly Patients After Drug-eluting Stent Implantation: an Evidence-based Clinical Review.
    Suwita BM; Laksmi PW; Wijaya IP
    Acta Med Indones; 2015 Jul; 47(3):253-64. PubMed ID: 26586393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Risk Factors of Benign Stricture of Anastomotic Stoma after Esophagectomy and Therapeutic Effect of Stent Implantation.
    International EM
    Emerg Med Int; 2024; 2024():9810434. PubMed ID: 38298982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of sirolimus-eluting stent implantation in patients with acute coronary syndrome in the real world.
    Kawaguchi R; Kimura T; Morimoto T; Oshima S; Hoshizaki H; Kawai K; Shiode N; Hiasa Y; Mitsudo K;
    Am J Cardiol; 2010 Dec; 106(11):1550-60. PubMed ID: 21094354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting versus bare metal stenting in acute myocardial infarction. A clinical review.
    Jones WS; Washam JB; Meine TJ; Patel MR
    Minerva Cardioangiol; 2009 Oct; 57(5):585-95. PubMed ID: 19838149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.
    von Birgelen C; Basalus MW; Tandjung K; van Houwelingen KG; Stoel MG; Louwerenburg JH; Linssen GC; Saïd SA; Kleijne MA; Sen H; Löwik MM; van der Palen J; Verhorst PM; de Man FH
    J Am Coll Cardiol; 2012 Apr; 59(15):1350-61. PubMed ID: 22341737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.
    Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Park SJ; Lee JH; Choi SW; Seong IW; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Choi YJ; Kim HS; Lee BK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Park WJ;
    J Am Coll Cardiol; 2011 Mar; 57(11):1264-70. PubMed ID: 21392640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.